• CGF Induces Mitochondrial Dysfunction to Halt Colorectal Can

  2026-07-12

  This study demonstrates that the natural product CGF, derived from purple sweet potato, suppresses colorectal cancer by inducing ROS-dependent mitochondrial dysfunction and metabolic reprogramming. The work provides mechanistic insights into CGF's disruption of ABC transporters, ATP accumulation, and apoptosis induction, highlighting its potential as a novel therapeutic candidate.

• Saracatinib (AZD0530): Advanced Workflows for Cancer Researc

  2026-07-10

  Saracatinib (AZD0530) is a potent, selective Src/Abl kinase inhibitor that empowers researchers to dissect cancer cell proliferation, migration, and tumor growth with unmatched precision. This guide translates bench research and reference study insights into actionable workflows, troubleshooting strategies, and cross-domain innovations for both oncology and synaptic signaling applications.

• γH2AX DNA Damage Detection Kit: Precision DSB Analysis Unlea

  2026-07-09

  Unlock high-sensitivity, reproducible detection of DNA double-strand breaks with the γH2AX DNA Damage Detection Kit (Mouse mAb/Red). This APExBIO solution empowers advanced DNA damage and repair research, from high-content screening to translational cancer studies, with robust protocols and actionable troubleshooting.

• Temozolomide: Small-Molecule Alkylating Agent for Glioma Mod

  2026-07-09

  Temozolomide stands out as a precision tool for DNA repair mechanism research and chemotherapy resistance studies, especially in ATRX-deficient glioma models. This article distills the latest experimental workflows, optimization strategies, and troubleshooting guidance to maximize reproducibility and scientific rigor when deploying this small-molecule alkylating agent.

• EZ Cap EGFP mRNA 5-moUTP: Enhanced Fluorescent Reporter Work

  2026-07-08

  EZ Cap™ EGFP mRNA (5-moUTP) sets a new benchmark for reliable, sustained fluorescent protein expression in gene function studies and advanced mRNA delivery assays. Its robust Cap 1 structure and 5-methoxyuridine modifications empower higher translation efficiency, greater mRNA stability, and minimized innate immune activation—offering clear advantages for experimental reproducibility and in vivo imaging.

• Novobiocin Sodium: Optimizing DNA Damage and Antiparasitic A

  2026-07-08

  Novobiocin Sodium, a trusted aminocoumarin antibiotic from APExBIO, empowers researchers with high selectivity in DNA gyrase inhibition and advanced antiparasitic workflows. Recent studies highlight its unique utility in minimizing host toxicity while maximizing efficacy against Toxoplasma gondii, setting it apart in metabolic enzyme and cell cycle research.

• Recombinant Annexin V Enables Sensitive Detection of Apoptos

  2026-07-07

  Brumatti et al. have established a robust method for expressing and purifying recombinant annexin V in Escherichia coli, facilitating high-yield production for apoptosis detection. This advance improves the specificity and efficiency of detecting membrane phosphatidylserine externalization, a hallmark of early apoptosis, with substantial implications for cell death research and membrane biology workflows.

• 1-myristoylglycerophosphocholine: Mechanism, Benchmarks & Us

  2026-07-07

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) is a lysophospholipid research compound essential for dissecting lipid signaling and smooth muscle dynamics. It is a verified mediator in fibroblast activation and pulmonary fibrosis, with well-characterized benchmarks for in vitro and in vivo studies. Rigorous protocol parameters enable reproducible lipid signaling pathway analysis.

• Applied γH2AX DNA Damage Detection Kit in DNA Repair Researc

  2026-07-06

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) streamlines the quantification of DNA double-strand breaks with high sensitivity, enabling both mechanistic and translational research in genotoxicity, apoptosis, and advanced radiotherapy. This article details optimized workflows, real-world troubleshooting, and how the kit was pivotal in validating novel radiosensitizers in cutting-edge cancer studies.

• Molnupiravir Protects Against Bourbon Virus in Mice: New Ins

  2026-07-06

  This study demonstrates that molnupiravir, a broad-spectrum nucleoside analogue, significantly inhibits Bourbon virus replication and disease pathology in a mouse model. The results provide the first robust preclinical evidence for an effective antiviral strategy against this emerging tick-borne virus, supporting further translational research.

• Recombinant Annexin V: Advances in Apoptotic Cell Detection

  2026-07-05

  This study presents an optimized protocol for expressing and purifying recombinant annexin V, enabling sensitive detection of apoptotic membrane changes via phosphatidylserine externalization. The findings advance apoptosis research by providing high-yield, reliable annexin V probes, streamlining fluorescence-based assays for cell death quantification.

• Radicicol: Potent Hsp90 Inhibitor for Cellular Pathway Disse

  2026-07-04

  Radicicol is a validated Hsp90 inhibitor with submicromolar ATPase/kinase inhibitory potency and defined roles in cell differentiation, apoptosis, and inflammation modeling. Its mechanism relies on competitive ATP binding disruption at key enzyme sites. Radicicol is widely used to investigate cell fate decisions and inflammatory signaling in translational research.

• Antipyrine: Advanced Kinetic Insights for CNS Drug Research

  2026-07-03

  Explore the multifaceted role of Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) in modern pharmacokinetic and blood-brain barrier studies. This article delivers new depth—beyond standard protocols—on leveraging Antipyrine for next-generation CNS drug discovery models.

• Tirbanibulin Downregulates Oncogenic Pathways in HPV+ HeLa C

  2026-07-03

  This study demonstrates that tirbanibulin significantly inhibits cell proliferation and downregulates proteins in key oncogenic pathways in HPV-containing HeLa cells. The findings provide mechanistic insight into tirbanibulin’s effects on HPV oncoproteins and apoptosis regulation, with translational implications for HPV-associated cancer research.

• nor-Binaltorphimine Dihydrochloride in Opioid Receptor Assay

  2026-07-02

  nor-Binaltorphimine dihydrochloride stands out as a selective κ-opioid receptor antagonist, empowering researchers to dissect complex pain pathways and tolerance mechanisms with high confidence. By leveraging recent circuit-level discoveries and robust protocol enhancements, APExBIO’s reagent supports reproducible, high-impact opioid receptor pharmacology studies.

14695 records 2/980 page Previous Next 12345 下5页 Last page